Latest Initial Public Offering News

Iron Road’s largest shareholder has distributed its remaining 59.72% stake just as the company prepares to restart delayed nickel-copper-gold drilling at Irria. The transition also includes the November retirement of long-serving chief executive Larry Ingle, with no successor named.

FMR Resources will sell its Fairfield copper-gold project to unlisted MFM Resources for $200,000 in MFM shares, subject to approvals, due diligence and MFM securing a proposed ASX listing. The deal marks a sharper concentration of FMR’s resources on its Chilean portfolio, but leaves shareholders exposed to the uncertainty of a future IPO and a non-cash consideration.

Innovaero Technologies is seeking A$40 million through a proposed ASX listing to advance its OWL loitering munition program and expand manufacturing capacity. The replacement prospectus also makes clear that the company remains loss-making and heavily dependent on the Department of Defence converting development work into production orders.

Daly Resources ended FY2026 with $11.05 million in cash after its $12 million IPO, but reported a $3.63 million loss dominated by share-based remuneration. The ASX-listed explorer has no defined mineral resources or ore reserves and must now convert its exploration portfolio into results.

Tali Resources ended its first full year as an ASX-listed explorer with A$5.19 million in cash, a larger West Arunta exploration program and a A$1.48 million loss. The annual report also records a A$516,170 impairment after early drilling returned only moderately anomalous results, keeping the company firmly in the high-risk pre-discovery phase.

Ceretas Limited posted a $1.63 million net loss for FY26 on $1.28 million revenue from government grants, advancing its clinical-stage Alzheimer’s ultrasound platform. The company completed an $8 million IPO in July to fund pivotal trials and device development.

Green & Gold Minerals posted a $886,828 loss for FY2026 amid a transformative year marked by its ASX listing and expansion into base metals exploration with the Herberton acquisition.

Epiminder Limited reported a $42.7 million loss for FY26, driven by clinical trial and product development costs following a $125 million IPO. The company progresses its FDA-approved Minder implantable EEG monitor with a pivotal US trial and next-gen device on track for 2028 launch.

Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.

Solaris Australian Equity Income Plus Limited (ASX:SET) has delivered a maiden profit and outperformed its benchmark since listing in April 2026, announcing initial fully franked monthly dividends.

Powerhaus Uranium launches an IPO to raise up to A$10 million, aiming to accelerate uranium exploration in underexplored Argentine provinces and acquire a Canadian Athabasca Basin project. The company’s flagship Malbec Project shows promising early-stage results, with plans for extensive drilling and in-situ recovery methods.

SCX.ai Holdings Limited is set to raise $40 million through a fully underwritten IPO at $0.30 per share, aiming to scale its sovereign AI inferencing platform built on ASIC hardware within Australian data centres. The company targets the fast-growing AI IaaS market with a focus on secure, low-latency AI workloads.